Danaher Corporation

NYSE:DHR Stock Report

Market Cap: US$153.9b

Danaher Balance Sheet Health

Financial Health criteria checks 5/6

Danaher has a total shareholder equity of $52.3B and total debt of $17.4B, which brings its debt-to-equity ratio to 33.2%. Its total assets and total liabilities are $81.6B and $29.3B respectively. Danaher's EBIT is $5.1B making its interest coverage ratio 19.8. It has cash and short-term investments of $3.0B.

Key information

33.16%

Debt to equity ratio

US$17.36b

Debt

Interest coverage ratio19.8x
CashUS$2.96b
EquityUS$52.34b
Total liabilitiesUS$29.28b
Total assetsUS$81.62b

Recent financial health updates

Recent updates

Danaher: Balanced Portfolio With Upside Potential In 2026

Oct 01

Some May Be Optimistic About Danaher's (NYSE:DHR) Earnings

Aug 01
Some May Be Optimistic About Danaher's (NYSE:DHR) Earnings

Is Danaher Corporation (NYSE:DHR) Trading At A 33% Discount?

Jul 12
Is Danaher Corporation (NYSE:DHR) Trading At A 33% Discount?

Is Danaher (NYSE:DHR) A Risky Investment?

May 22
Is Danaher (NYSE:DHR) A Risky Investment?

Danaher Corporation's (NYSE:DHR) Popularity With Investors Is Clear

May 07
Danaher Corporation's (NYSE:DHR) Popularity With Investors Is Clear

Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations

Mar 31

Estimating The Fair Value Of Danaher Corporation (NYSE:DHR)

Mar 26
Estimating The Fair Value Of Danaher Corporation (NYSE:DHR)

Danaher: Near 5-Year Low Is A Great Entry Point

Mar 22

Danaher Corporation Just Missed EPS By 5.5%: Here's What Analysts Think Will Happen Next

Feb 24
Danaher Corporation Just Missed EPS By 5.5%: Here's What Analysts Think Will Happen Next

Danaher: Self-Inflicted Pessimism?

Feb 17

Investors Appear Satisfied With Danaher Corporation's (NYSE:DHR) Prospects

Jan 27
Investors Appear Satisfied With Danaher Corporation's (NYSE:DHR) Prospects

Danaher Corporation: Question Mark Behind The Moat And Probably Overvalued

Jan 15

At US$238, Is Danaher Corporation (NYSE:DHR) Worth Looking At Closely?

Jan 10
At US$238, Is Danaher Corporation (NYSE:DHR) Worth Looking At Closely?

Danaher: A Wide-Moat Gem I Cannot Buy Enough Of

Jan 06

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Dec 26
Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher: A Resilient And Solid Company With Growth Potential

Dec 10

Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly

Dec 08
Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly

Understanding Danaher's Cautiousness

Oct 25

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Sep 25

Danaher: Lofty Price, Bright Future

Aug 22

Danaher: Valuation Now Too High Even Compared To Own High Standards

Jul 16

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27
User avatar

Strategic Spin-off and Innovations To Deliver Durable Growth and Stronger Financial Health

Danaher's focus on life sciences and diagnostics through a spin-off and strategic acquisitions aims to secure durable growth in future revenue and earnings.

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Financial Position Analysis

Short Term Liabilities: DHR's short term assets ($11.0B) exceed its short term liabilities ($6.8B).

Long Term Liabilities: DHR's short term assets ($11.0B) do not cover its long term liabilities ($22.5B).


Debt to Equity History and Analysis

Debt Level: DHR's net debt to equity ratio (27.5%) is considered satisfactory.

Reducing Debt: DHR's debt to equity ratio has reduced from 62.5% to 33.2% over the past 5 years.

Debt Coverage: DHR's debt is well covered by operating cash flow (35.5%).

Interest Coverage: DHR's interest payments on its debt are well covered by EBIT (19.8x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 01:51
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/27
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Danaher Corporation is covered by 53 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John EadeArgus Research Company
Catherine Ramsey SchulteBaird
Luke SergottBarclays